Safety and efficacy of modified dose-attenuated FOLFIRINOX chemotherapy in patients over 65 years with advanced pancreatic adenocarcinoma. This is an ASCO Meeting Abstract from the 2013 ASCO Annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results